Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links.

Hutchinson E, Parkhurst J, Phiri S, Gibb DM, Chishinga N, Droti B, Hoskins S.

Health Res Policy Syst. 2011 Jun 16;9 Suppl 1:S6. doi: 10.1186/1478-4505-9-S1-S6.

3.

Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.

Harries AD, Zachariah R, Chimzizi R, Salaniponi F, Gausi F, Kanyerere H, Schouten EJ, Jahn A, Makombe SD, Chimbwandira FM, Mpunga J.

BMC Public Health. 2011 Jul 27;11:593. doi: 10.1186/1471-2458-11-593.

4.

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.

Ryan M, Griffin S, Chitah B, Walker AS, Mulenga V, Kalolo D, Hawkins N, Merry C, Barry MG, Chintu C, Sculpher MJ, Gibb DM.

AIDS. 2008 Mar 30;22(6):749-57. doi: 10.1097/QAD.0b013e3282f43519.

PMID:
18356605
5.

Incorporating research evidence into decision-making processes: researcher and decision-maker perceptions from five low- and middle-income countries.

Shroff Z, Aulakh B, Gilson L, Agyepong IA, El-Jardali F, Ghaffar A.

Health Res Policy Syst. 2015 Nov 30;13:70. doi: 10.1186/s12961-015-0059-y.

6.

Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy.

Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, Parkhurst J.

Bull World Health Organ. 2011 Apr 1;89(4):312-6. doi: 10.2471/BLT.10.077743. Epub 2011 Feb 28.

7.

National policy-makers speak out: are researchers giving them what they need?

Hyder AA, Corluka A, Winch PJ, El-Shinnawy A, Ghassany H, Malekafzali H, Lim MK, Mfutso-Bengo J, Segura E, Ghaffar A.

Health Policy Plan. 2011 Jan;26(1):73-82. doi: 10.1093/heapol/czq020. Epub 2010 Jun 14.

8.

Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.

Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):336-43.

PMID:
17327758
9.

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design.

Anywaine Z, Abaasa A, Levin J, Kasirye R, Kamali A, Grosskurth H, Munderi P, Nunn A.

Contemp Clin Trials. 2015 Jul;43:100-4. doi: 10.1016/j.cct.2015.05.015. Epub 2015 May 22.

10.

Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach.

Bardfield J, Agins B, Palumbo M, Wei AL, Morris J, Marston B; Cotrimoxazole Qi Group.

Int J Qual Health Care. 2014 Dec;26(6):613-22. doi: 10.1093/intqhc/mzu085. Epub 2014 Oct 21.

PMID:
25335758
11.

Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.

Grimwade K, Swingler GH.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003508. Review.

PMID:
16437457
12.
13.
14.

Towards building equitable health systems in Sub-Saharan Africa: lessons from case studies on operational research.

Theobald S, Taegtmeyer M, Squire SB, Crichton J, Simwaka BN, Thomson R, Makwiza I, Tolhurst R, Martineau T, Bates I.

Health Res Policy Syst. 2009 Nov 25;7:26. doi: 10.1186/1478-4505-7-26.

15.

Uptake of evidence in policy development: the case of user fees for health care in public health facilities in Uganda.

Nabyonga-Orem J, Ssengooba F, Mijumbi R, Tashobya CK, Marchal B, Criel B.

BMC Health Serv Res. 2014 Dec 18;14:639. doi: 10.1186/s12913-014-0639-5.

16.
17.

The use of economic evaluations in NHS decision-making: a review and empirical investigation.

Williams I, McIver S, Moore D, Bryan S.

Health Technol Assess. 2008 Apr;12(7):iii, ix-x, 1-175.

18.

Intelligent policy making? Key actors' perspectives on the development and implementation of an early years' initiative in Scotland's public health arena.

Deas L, Mattu L, Gnich W.

Soc Sci Med. 2013 Nov;96:1-8. doi: 10.1016/j.socscimed.2013.07.001. Epub 2013 Jul 13.

PMID:
24034945
19.

Translations of health sector SWAps--a comparative study of health sector development cooperation in Uganda, Zambia and Bangladesh.

Sundewall J, Sahlin-Andersson K.

Health Policy. 2006 May;76(3):277-87. Epub 2005 Jul 20. Review.

PMID:
16039002
20.

The impact of Fogarty International Center research training programs on public health policy and program development in Kenya and Uganda.

Bennett S, Paina L, Ssengooba F, Waswa D, M'Imunya JM.

BMC Public Health. 2013 Aug 21;13:770. doi: 10.1186/1471-2458-13-770.

Supplemental Content

Support Center